Prevenar 13® is a PCV
Help protect your adult patients against pneumococcal pneumonia with
Efficacy proven by the CAPiTA study
The ACIP recommends routine use of PCV13 among adults
FAQs related to different fields
Review the upcoming events
ACIP, Advisory Committee on Immunization Practices; PCV, pneumococcal conjugate vaccine; PCV 13, 13-valent pneumococcal conjugate vaccine.
Please click the Prescribing Information link to view the safety and adverse events information of Prevenar 13®.
For the use only of Registered Medical Practitioners or a Hospital or a Laboratory.
PP-PRV-IND-0268 July 2022
These pages are not intended for patients or for members of the general public. The web pages contain promotional content.
If you select 'No', you will be redirected to Pfizer.co.in
For more details on, Who is a Registered Medical Practitioner*, please visit
https://cdsco.gov.in/opencms/export/sites/CDSCO_WEB/Pdf-documents/acts_rules/2016DrugsandCosmeticsAct1940Rules1945.pdf , Page No. 39, Rule 2 part (ee), last accessed on 13th September 2019.
Address: The Capital, A Wing, 1802, 18th Floor, Plot No. C-70, 'G' Block, Bandra Kurla Complex, Bandra East, Mumbai - 400051.